Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COPD
COPD
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
COPD
Sanofi
Regeneron
Verona Pharma
Dupixent
ensifentrine
After decades of waiting, late-stage therapies may penetrate the COPD market this year
Clinical Trials Arena
Sun, 03/24/24 - 10:31 pm
COPD
drug development
Sanofi
Regeneron
Dupixent
Verona
ensifentrine
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
GSK
Boehringer Ingelheim
AstraZeneca
drug pricing
COPD
asthma
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
AstraZeneca
inhalers
drug pricing
Boehringer Ingelheim
Airsupra
Bevespi Aerosphere
Breztri Aerosphere
COPD
AstraZeneca kick-starts Phase III COPD trial for Breztri
Clinical Trials Arena
Thu, 03/14/24 - 11:21 am
AstraZeneca
COPD
clinical trials
Breztri
Boehringer to cap out-of-pocket inhaler cost at $35 per month
Reuters
Thu, 03/7/24 - 11:08 am
Boehringer Ingelheim
drug pricing
Atrovent
Combivent Respimat
Spiriva HandiHale
COPD
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
FDA
Sanofi
Regeneron
Dupixent
priority review
COPD
4 biotechs to watch in 2024
Pharma Voice
Wed, 02/21/24 - 11:28 am
biotech
IPOs
Alto Neuroscience
Verona Pharma
Karuna Therapeutics
Madrigal Pharmaceuticals
precision medicine
COPD
Alzheimer's disease
NASH
Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
Fierce Pharma
Sun, 01/7/24 - 04:07 pm
Theravance
Yupelri
COPD
Boehringer Ingelheim
Spiriva
Verona Gets $400M Boost from Oxford Finance, Hercules Capital for COPD Candidate
BioSpace
Wed, 01/3/24 - 09:51 am
Verona Pharma
COPD
funding
Sanofi, Regeneron eye Dupixent label expansion with promising COPD data
Medical Marketing and Media
Tue, 11/28/23 - 10:27 am
Sanofi
Regeneron
Dupixent
clinical trials
COPD
Viatris and Theravance report data from COPD treatment trial
Clinical Trials Arena
Tue, 11/14/23 - 09:24 am
Viatris
Theravance
clinical trials
Yupelri
COPD
Samay’s AI-enabled wearable ‘can diagnose COPD’
Pharmaphorum
Thu, 11/2/23 - 11:38 am
Medtech
diagnostics
Samay
Sylvee
artificial intelligence
COPD
FDA warns AstraZeneca over false advertising of COPD drug
Beckers Hospital Review
Thu, 08/17/23 - 09:52 am
AstraZeneca
COPD
FDA
Breztri Aerosphere
DTC advertising
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Mon, 05/22/23 - 10:16 am
Sanofi
Regeneron
COPD
Dupixent
Aer Therapeutics Raises $36M for Novel Approach to COPD
BioSpace
Fri, 04/14/23 - 10:04 am
Aer Therapeutics
COPD
funding
Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
Fierce Pharma
Sun, 03/26/23 - 11:30 pm
Sanofi
Regeneron
Dupixent
COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
AAD: Will Sanofi and Regeneron’s Dupixent be a game-changer or just another antibody on the COPD scrapheap?
Fierce Pharma
Mon, 03/20/23 - 10:06 am
Sanofi
Regeneron
Dupixent
COPD
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »